Alnylam Pharmaceuticals, Inc. ALNY

Source

US equities market feed

Observed

Sep 4, 2026, 12:00 AM

Cadence

Five-minute page cache; daily and stored hourly bars

Status

fresh

Open

$259.20

Previous Close

$264.37

Day High

$266.67

Day Low

$259.20

52 Week High

$378.45

52 Week Low

$197.95

7 Day Return

+12.06%

30 Day Return

+16.10%

90 Day Return

-9.08%

1 Year Return

-10.26%

Daily Notional Volume

$13.5M

Latest daily bar volume multiplied by its closing price.

P/E (TTM)

37.61

Trailing twelve-month price-to-earnings ratio. Higher means the market is pricing in more growth. Negative or missing when earnings are negative.

Forward P/E

—

P/E based on consensus forward EPS estimates. Lower versus trailing implies expected earnings growth.

EPS (TTM)

$2.33

Diluted earnings per share over the trailing twelve months.

Beta

0.34

Volatility relative to the index. 1.00 equals market, above 1 amplifies the broad-market move, below 1 dampens it.

Dividend Yield

—

Annual dividend per share divided by current price. Zero or blank when the company does not pay a dividend.

Profit Margin

16.8%

Net income divided by revenue. Comparable within a sector, less so across sectors.

52w range

$197.81 – $495.55

Lowest and highest closing prices over the past 52 weeks.

Analyst Target

—

Mean of sell-side analyst 12-month price targets. Use as a sentiment gauge; targets are biased upward in aggregate.

Display-only. Refreshed once per symbol per 24 hours · market cap $30.4B · P/B 66.57 · P/S 6.33.